Cancer Cell

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instance_of gptkb:Cell
gptkbp:amended_by Microenvironment
gptkbp:can_arise_from Normal cells
gptkbp:can_be_used_to Alternative energy sources
gptkbp:can_cause Tumors
gptkbp:can_create Tumor markers
gptkbp:can_detect Biopsy
gptkbp:can_develop_resistance_to Treatment
gptkbp:can_evade Apoptosis
gptkbp:can_exhibit_resistance_to Apoptotic signals
gptkbp:can_metastasize_to gptkb:Yes
gptkbp:can_secrete Exosomes
gptkbp:characteristic Uncontrolled growth
gptkbp:defeated Surrounding tissues
gptkbp:exhibits Heterogeneity
Epithelial-mesenchymal transition
Drug resistance mechanisms
Invasion properties
Stem cell-like properties
https://www.w3.org/2000/01/rdf-schema#label Cancer Cell
gptkbp:influence Systemic metabolism
gptkbp:initiated_by Tumor suppressor genes
gptkbp:interacts_with Immune cells
gptkbp:is_affected_by Environmental factors
Lifestyle factors
Chemotherapy
Radiation therapy
Hormonal therapy
gptkbp:is_analyzed_in Genomic sequencing
gptkbp:is_associated_with Genetic mutations
gptkbp:is_characterized_by Genomic instability
Altered signaling pathways
Abnormal cell cycle regulation
gptkbp:is_described_as gptkb:immortal
Aggressive
Aneuploid
Metabolically active
Proliferative.
gptkbp:is_influenced_by gptkb:Biology
gptkbp:is_monitored_by Imaging techniques
gptkbp:is_recognized_by Immunohistochemistry
Histological examination
gptkbp:is_studied_in gptkb:Oncology
Clinical trials
Cell culture
Animal models
gptkbp:is_targeted_at Monoclonal antibodies
Targeted therapy
Small molecule inhibitors
gptkbp:occurs_in Metabolic reprogramming
gptkbp:participated_in Angiogenesis
gptkbp:released Growth factors
gptkbp:scientific_classification gptkb:Malignant
Liquid tumor
Solid tumor
Type of cancer
gptkbp:treatment gptkb:immunotherapy
gptkb:surgery
Combination therapy
gptkbp:bfsParent gptkb:Bert_Vogelstein
gptkb:Cell_Press
gptkbp:bfsLayer 5